메뉴 건너뛰기




Volumn 17, Issue 2, 2007, Pages 125-128

Design and evaluation of a floating ranitidine tablet as a drug delivery system for oral application

Author keywords

Floating drug delivery systems; Ranitidine

Indexed keywords

BICARBONATE; DRUG ADDITIVE; HYDROXYPROPYLMETHYLCELLULOSE; METHYLCELLULOSE; RANITIDINE; WATER;

EID: 34247133457     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(07)50019-5     Document Type: Article
Times cited : (6)

References (17)
  • 1
    • 0345035517 scopus 로고    scopus 로고
    • Floating or pulsatile drug delivery systems based on coated effervescent cores
    • Krögel I., Bodmeier R. - Floating or pulsatile drug delivery systems based on coated effervescent cores. - Int. J. Pharm., 187, 175-84, 1999.
    • (1999) Int. J. Pharm , vol.187 , pp. 175-184
    • Krögel, I.1    Bodmeier, R.2
  • 2
    • 0033991593 scopus 로고    scopus 로고
    • Floating drug delivery systems: An approach to oral controlled drug delivery via gastric retention
    • Singh B.N., Kim K.H. - Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. - J. of Controlled Release, 63, 235-59, 2000.
    • (2000) J. of Controlled Release , vol.63 , pp. 235-259
    • Singh, B.N.1    Kim, K.H.2
  • 3
    • 0036025241 scopus 로고    scopus 로고
    • Effect of formulation variables on the floating properties of gastric floating drug delivery system
    • Li S., Lin S., Daggy B.P., Mirchandani H.L., Chien Y.W. - Effect of formulation variables on the floating properties of gastric floating drug delivery system. - Drug Dev. Ind. Pharm., 28 (7), 783-93, 2002.
    • (2002) Drug Dev. Ind. Pharm , vol.28 , Issue.7 , pp. 783-793
    • Li, S.1    Lin, S.2    Daggy, B.P.3    Mirchandani, H.L.4    Chien, Y.W.5
  • 4
    • 0034951999 scopus 로고    scopus 로고
    • Design and evaluation of a two-layer floating tablet for gastric retention using Cisapride as a model drug
    • Wei Z., Yu Z., Bi D. - Design and evaluation of a two-layer floating tablet for gastric retention using Cisapride as a model drug. - Drug Dev. Ind. Pharm., 27 (5), 469-74, 2001.
    • (2001) Drug Dev. Ind. Pharm , vol.27 , Issue.5 , pp. 469-474
    • Wei, Z.1    Yu, Z.2    Bi, D.3
  • 5
    • 0027180264 scopus 로고
    • A floating controlled-release drug delivery system: In vitro-in vivo evaluation
    • Desai S., Bolton S. - A floating controlled-release drug delivery system: in vitro-in vivo evaluation. - J. Pharm. Res., 10 (9), 1321-25, 1993.
    • (1993) J. Pharm. Res , vol.10 , Issue.9 , pp. 1321-1325
    • Desai, S.1    Bolton, S.2
  • 6
    • 0034111376 scopus 로고    scopus 로고
    • PVP solid dispersions for the controlled release of furosemide from a floating multiple-unit system
    • Iannuccelli V., Coppi G., Leo E., Fontana F., Bernabei M.T. - PVP solid dispersions for the controlled release of furosemide from a floating multiple-unit system. - Drug Dev. Ind. Pharm., 26 (6), 595-603, 2000.
    • (2000) Drug Dev. Ind. Pharm , vol.26 , Issue.6 , pp. 595-603
    • Iannuccelli, V.1    Coppi, G.2    Leo, E.3    Fontana, F.4    Bernabei, M.T.5
  • 7
    • 0031681217 scopus 로고    scopus 로고
    • In vitro performance of floating sustained-release capsule of verapamil
    • Chen G.L., Hao W.H. - In vitro performance of floating sustained-release capsule of verapamil. - Drug Dev. Ind. Pharm., 24 (11), 1067-72, 1998.
    • (1998) Drug Dev. Ind. Pharm , vol.24 , Issue.11 , pp. 1067-1072
    • Chen, G.L.1    Hao, W.H.2
  • 8
    • 0033935589 scopus 로고    scopus 로고
    • Studies of floating dosage forms of furosemide: In vitro and In vivo evaluation of bilayer tablet formulations
    • Ozdemir N., Ordu S., Ozkan Y. - Studies of floating dosage forms of furosemide: In vitro and In vivo evaluation of bilayer tablet formulations. - Drug Dev. Ind. Pharm., 26 (8), 857-66, 2000.
    • (2000) Drug Dev. Ind. Pharm , vol.26 , Issue.8 , pp. 857-866
    • Ozdemir, N.1    Ordu, S.2    Ozkan, Y.3
  • 9
    • 0025113446 scopus 로고
    • How well do floating dosage forms float?
    • Timmermans J., Moës A.J. - How well do floating dosage forms float? - Int. J. Pharm., 62, 207-16, 1990.
    • (1990) Int. J. Pharm , vol.62 , pp. 207-216
    • Timmermans, J.1    Moës, A.J.2
  • 10
    • 0029117539 scopus 로고
    • Optimization of sotalol floating and bioadhesive extended release tablet formulations
    • Chueh H.R., Zia H., Rhodes C.T. - Optimization of sotalol floating and bioadhesive extended release tablet formulations. - Drug Dev. Ind. Pharm., 2 (15), 1725-47, 1995.
    • (1995) Drug Dev. Ind. Pharm , vol.2 , Issue.15 , pp. 1725-1747
    • Chueh, H.R.1    Zia, H.2    Rhodes, C.T.3
  • 11
    • 0028230322 scopus 로고
    • Design and testing in vitro of a bioadhesive and floating drug delivery system for oral application
    • Jiménez-Castellanos M.R., Zia H., Rhodes C.T. - Design and testing in vitro of a bioadhesive and floating drug delivery system for oral application. - Int. J. Pharm., 105, 65-70, 1994.
    • (1994) Int. J. Pharm , vol.105 , pp. 65-70
    • Jiménez-Castellanos, M.R.1    Zia, H.2    Rhodes, C.T.3
  • 12
    • 0035946031 scopus 로고    scopus 로고
    • Rapid determination of ranitidine in human plasma by high performance liquid chromatography without solvent extraction
    • Ahmadiani A., Amini H. - Rapid determination of ranitidine in human plasma by high performance liquid chromatography without solvent extraction. - J. Chromatogr. Biomed. Sci. Appl., 751 (2), 291-96, 2001.
    • (2001) J. Chromatogr. Biomed. Sci. Appl , vol.751 , Issue.2 , pp. 291-296
    • Ahmadiani, A.1    Amini, H.2
  • 13
    • 0033930927 scopus 로고    scopus 로고
    • Captopril floating and/or bioadhesive tablets: Design and release kinetics
    • Nur R.O., Zhang J.S. - Captopril floating and/or bioadhesive tablets: Design and release kinetics. - Drug Dev. Ind. Pharm., 26 (9), 965-69, 2000.
    • (2000) Drug Dev. Ind. Pharm , vol.26 , Issue.9 , pp. 965-969
    • Nur, R.O.1    Zhang, J.S.2
  • 14
    • 0033974459 scopus 로고    scopus 로고
    • Optimisation of floating matrix tablets and evaluation of the gastric residence time
    • Baumgartner S., Kristl J., Vrecer F., Vodopivec P., Zorko B. - Optimisation of floating matrix tablets and evaluation of the gastric residence time. - Int. J. Pharm., 195 (1-2), 125-35, 2000.
    • (2000) Int. J. Pharm , vol.195 , Issue.1-2 , pp. 125-135
    • Baumgartner, S.1    Kristl, J.2    Vrecer, F.3    Vodopivec, P.4    Zorko, B.5
  • 15
    • 0032443379 scopus 로고    scopus 로고
    • Drug diffusion and binding in ionizable interpenetrating network from poly(vinyl alcohol) and poly(acrylic acid)
    • Peppas N.A., Wright S.L. - Drug diffusion and binding in ionizable interpenetrating network from poly(vinyl alcohol) and poly(acrylic acid). - Eur. J. Pharm. Biopharm., 46, 15-29, 1998.
    • (1998) Eur. J. Pharm. Biopharm , vol.46 , pp. 15-29
    • Peppas, N.A.1    Wright, S.L.2
  • 16
    • 0027466516 scopus 로고
    • Floating and swelling characteristics of various excipients used in controlled release technology
    • Gerogiannis V.S., Rekkas D.M., Dallas P.P., Choulis N.H. - Floating and swelling characteristics of various excipients used in controlled release technology. - Drug Dev. Ind. Pharm., 19 (9), 1061-81, 1993.
    • (1993) Drug Dev. Ind. Pharm , vol.19 , Issue.9 , pp. 1061-1081
    • Gerogiannis, V.S.1    Rekkas, D.M.2    Dallas, P.P.3    Choulis, N.H.4
  • 17
    • 0037237902 scopus 로고    scopus 로고
    • Floating matrix tablets based on low density foam powder: Effects of formulation and processing parameters on drug release
    • Streubel A., Siepmann J., Bodmeier R. - Floating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug release. - Eur. J. Pharm. Sci., 18, 37-45, 2003.
    • (2003) Eur. J. Pharm. Sci , vol.18 , pp. 37-45
    • Streubel, A.1    Siepmann, J.2    Bodmeier, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.